Secondly, unlike previous studies that did not specifically target at-risk individuals, our cohort consists of individuals with a high a priori risk of AD, as indicated by a family history of AD and/or presence of the APOE4 genotype. This evidence concerns the gene APOE and Alzheimer disease.